Cargando…
REBECA trial: a new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798534/ https://www.ncbi.nlm.nih.gov/pubmed/35117383 http://dx.doi.org/10.21037/tcr.2019.12.83 |
| _version_ | 1784641831031537664 |
|---|---|
| author | Lavacchi, Daniele Fancelli, Sara Gatta Michelet, Marta Rita Catalano, Martina Roviello, Giandomenico |
| author_facet | Lavacchi, Daniele Fancelli, Sara Gatta Michelet, Marta Rita Catalano, Martina Roviello, Giandomenico |
| author_sort | Lavacchi, Daniele |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8798534 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87985342022-02-02 REBECA trial: a new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer Lavacchi, Daniele Fancelli, Sara Gatta Michelet, Marta Rita Catalano, Martina Roviello, Giandomenico Transl Cancer Res Editorial Commentary AME Publishing Company 2020-02 /pmc/articles/PMC8798534/ /pubmed/35117383 http://dx.doi.org/10.21037/tcr.2019.12.83 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
| spellingShingle | Editorial Commentary Lavacchi, Daniele Fancelli, Sara Gatta Michelet, Marta Rita Catalano, Martina Roviello, Giandomenico REBECA trial: a new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer |
| title | REBECA trial: a new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer |
| title_full | REBECA trial: a new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer |
| title_fullStr | REBECA trial: a new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer |
| title_full_unstemmed | REBECA trial: a new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer |
| title_short | REBECA trial: a new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer |
| title_sort | rebeca trial: a new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798534/ https://www.ncbi.nlm.nih.gov/pubmed/35117383 http://dx.doi.org/10.21037/tcr.2019.12.83 |
| work_keys_str_mv | AT lavacchidaniele rebecatrialanewpieceoftheevidenceforbevacizumabinplatinumresistantrecurrentovariancancer AT fancellisara rebecatrialanewpieceoftheevidenceforbevacizumabinplatinumresistantrecurrentovariancancer AT gattamicheletmartarita rebecatrialanewpieceoftheevidenceforbevacizumabinplatinumresistantrecurrentovariancancer AT catalanomartina rebecatrialanewpieceoftheevidenceforbevacizumabinplatinumresistantrecurrentovariancancer AT roviellogiandomenico rebecatrialanewpieceoftheevidenceforbevacizumabinplatinumresistantrecurrentovariancancer |